Douglas Adkins, MD
Enriched profileProfessor of Medicine, Division of Oncology, Section of Medical Oncology · Washington University in St. Louis
Douglas Adkins is Professor of Medicine, Division of Oncology, Section of Medical Oncology at Washington University in St. Louis. OpenAlex indexes 569 publications with 14,605 citations (h-index 53); ClinicalTrials.gov lists 25 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Douglas Adkins, MD, is Professor of Medicine, Division of Oncology, Section of Medical Oncology at Washington University in St. Louis / Siteman Cancer Center. The public record shows 569 publications with 14,605 citations (h-index 53), centered on Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 17 companies.
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Head and Neck Cancer Studies
- 25 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 181.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:
- CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
Sponsor: Washington University School of Medicine
- Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor: Washington University School of Medicine
- 5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Sponsor: Washington University School of Medicine
Industry payments
Updated 18 Oct 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202519 payments$19,262openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20257 payments
- AstraZeneca UK LimitedProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
37%Corticosteroid37%Dexamethasone sodium phosphate89%Dexamethasone11%Part D + Part B≥31 patientsMetabolism & gastrointestinal
25%Serotonin-3 Receptor Antagonist17.5%Palonosetron hcl100%Part B, office-administered≥21 patientsCorticosteroid6.8%Prednisone100%Part D≥23 patients+ 1 more class in this area
Nervous system
14.5%Opioid Agonist8.9%Oxycodone Hcl47%Fentanyl23%Morphine Sulfate11%Morphine Sulfate Er10%Methadone Hcl10%Part D<11 patientsPhenothiazine3.4%Prochlorperazine Maleate100%Part D≥36 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 18 Oct 2026
102 congress contributions (2006–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.
Journal of clinical oncology
Clinical Trial2026 - Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.
Cancer research communications
Clinical Trial2026 - Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyArticle1,360 citations2020
- 03
- 04NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018Article614 citations2018
- 05NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022Article527 citations2022
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
profiles.wustl.edu/en/persons/douglas-adkins
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.wustl.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siteman.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siteman.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siteman.washu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Randall Bateman, MD
Washington University in St. Louis
Janet McGill, MD
Washington University in St. Louis
Robert Carney, MD
Washington University in St. Louis
David Clifford, MD
Washington University in St. Louis
Neal Futran, MD
University of Washington (UW Medicine)
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Antonio Jimeno, MD
University of Colorado Cancer Center